We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$252B
AUM Growth
-$7.74B
Cap. Flow
-$10.2B
Cap. Flow %
-4.03%
Top 10 Hldgs %
22.68%
Holding
10,737
New
1,370
Increased
3,710
Reduced
4,352
Closed
1,178

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Consumer Discretionary 2.02%
3 Financials 1.63%
4 Healthcare 1.38%
5 Energy 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEEL
10151
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
-$66K
VTNR
10152
PUT
DELISTED
Vertex Energy, Inc
VTNR
-14,300
Closed -$100K
EGIO
10153
PUT
DELISTED
Edgio, Inc. Common Stock
EGIO
-260
Closed -$24K
ALIM
10154
CALL
DELISTED
Alimera Sciences
ALIM
-15,507
Closed -$1.26M
HOLI
10155
CALL
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-11,600
Closed -$261K
HOLI
10156
PUT
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-12,800
Closed -$288K
WIRE
10157
CALL
DELISTED
Encore Wire Corp
WIRE
-11,400
Closed -$423K
SIX
10158
PUT
DELISTED
Six Flags Entertainment Corp.
SIX
-95,900
Closed -$3.3M
BIOL
10159
DELISTED
Biolase, Inc.
BIOL
-1
Closed -$25K
BIOL
10160
PUT
DELISTED
Biolase, Inc.
BIOL
-1
Closed -$34K
ERF
10161
DELISTED
Enerplus Corporation
ERF
-34,997
Closed -$473K
ENG
10162
DELISTED
ENGlobal Corp
ENG
-1,622
Closed -$28K
ENG
10163
PUT
DELISTED
ENGlobal Corp
ENG
-1,713
Closed -$29K
NBSE
10164
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-82
Closed -$238K
AEL
10165
CALL
DELISTED
American Equity Investment Life Holding Company
AEL
-19,700
Closed -$451K
AEL
10166
PUT
DELISTED
American Equity Investment Life Holding Company
AEL
-13,200
Closed -$302K
PGTI
10167
PUT
DELISTED
PGT, Inc.
PGTI
-10,200
Closed -$95K
TGH
10168
CALL
DELISTED
Textainer Group Holdings limited
TGH
-17,600
Closed -$548K
NEPT
10169
CALL
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-23
Closed -$62K
DMK
10170
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-227
Closed -$74K
GOL
10171
CALL
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-17,700
Closed -$170K
SRT
10172
CALL
DELISTED
Startek Inc.
SRT
-51,900
Closed -$402K
PACW
10173
PUT
DELISTED
PacWest Bancorp
PACW
-5,800
Closed -$239K
LTRPA
10174
CALL
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
-8,300
Closed -$281K
SNLN
10175
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
-10,699
Closed -$208K

Similar funds

Jeff Yass's Q4 2014 Portfolio in Review

As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jeff Yass withdrew a net $10.2B in Q4 2014, closing 1,178 positions and reducing 4,352 holdings. Its most notable exit was Bausch Health, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in Northern Trust Morningstar Global Upstream Natural Resources ETF worth $31M.

  • Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
  • Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
  • Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
  • Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
  • Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
  • Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.

Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.